These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 6457476

  • 1. [Approaches to the study of dopamine metabolism in various extrapyramidal diseases].
    Barkhatova VP, Kandel' EI, Demina EG.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(7):1021-9. PubMed ID: 6457476
    [Abstract] [Full Text] [Related]

  • 2. Approaches to the study of cerebral dopamine metabolism in certain extrapyramidal diseases.
    Barkhatova VP, Kandel' EI, Demina EG.
    Neurosci Behav Physiol; 1985; 15(2):132-9. PubMed ID: 3160969
    [No Abstract] [Full Text] [Related]

  • 3. [Indicators of brain biogenic amine metabolism in various extrapyramidal disorders].
    Barchatowa WP, Milewska D, Wehr H.
    Neurol Neurochir Pol; 1981; 15(4):381-6. PubMed ID: 6173791
    [Abstract] [Full Text] [Related]

  • 4. [Central metabolism of dopamine and serotonin. II. Significance of cerebrospinal fluid HVA and 5-HIAA changes in extrapyramidal and cerebellar syndromes].
    Buscaino GA, Mandarini A, Campanella G, Carrieri P, Orefice G.
    Acta Neurol (Napoli); 1976; 31(5):565-70. PubMed ID: 138340
    [No Abstract] [Full Text] [Related]

  • 5. [Homovanillic acid content in the cerebrospinal fluid as an index of dopamine cerebral metabolism before and after a stereotaxic operation in patients with extrapyramidal hyperkinetic syndromes].
    Barkhatova VP, Kandel' EI, Omorova TM, Demina EG.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(7):1050-5. PubMed ID: 6382885
    [Abstract] [Full Text] [Related]

  • 6. [HVA and 5-HIAA in the cerebrospinal fluid in extrapyramidal and cerebrellar syndromes. Preliminary data].
    Carrieri P, Mandarini A, Campanella G.
    Acta Neurol (Napoli); 1975; 30(5):449-54. PubMed ID: 132845
    [No Abstract] [Full Text] [Related]

  • 7. [Role of catecholamines in the pathogenesis of extrapyramidal hyperkinesis].
    Barkhatova VP.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(2):212-9. PubMed ID: 2939669
    [Abstract] [Full Text] [Related]

  • 8. CSF homovanillic acid: an index of dopaminergic activity.
    Curzon G.
    Adv Neurol; 1975; 9():349-57. PubMed ID: 125031
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Biochemical aids in the diagnosis of Parkinson's disease.
    Chase TN, Eng N, Gordon EK.
    Ann Clin Lab Sci; 1976; 6(1):4-10. PubMed ID: 1247283
    [Abstract] [Full Text] [Related]

  • 11. 14C-homovanillic acid in the cerebrospinal fluid of parkinsonian patients after intravenous 14C-L-dopa.
    Extein I, Van Woert M, Roth RH, Bowers MB.
    Biol Psychiatry; 1976 Apr; 11(2):227-32. PubMed ID: 971447
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Central metabolism of dopamine and serotonin. III. Preliminary findings on the relations between dopamine metabolism and purine metabolism in the nervous system].
    Campanella G, Orefice G, Carrieri P, Mandarini A, Buscaino GA.
    Acta Neurol (Napoli); 1976 Apr; 31(5):571-9. PubMed ID: 138341
    [No Abstract] [Full Text] [Related]

  • 17. The ventricular fluid pressure and the concentration of homovanillic acid in different parts of the cerebrospinal fluid system in patients with Parkinson's disease.
    West KA, Roos BE.
    Confin Neurol; 1972 Apr; 34(2):136-42. PubMed ID: 4579783
    [No Abstract] [Full Text] [Related]

  • 18. Monoamine metabolites and neuropeptides in patients with Parkinson's disease, Huntington's chorea, Shy-Drager syndrome, and torsion dystonia.
    Lindvall B, Olsson JE.
    Adv Neurol; 1990 Apr; 53():117-22. PubMed ID: 1700581
    [No Abstract] [Full Text] [Related]

  • 19. CSF studies on the relationship between dopamine and 5-hydroxytryptamine in Parkinsonism and other movement disorders.
    Davidson DL, Yates CM, Mawdsley C, Pullar IA, Wilson H.
    J Neurol Neurosurg Psychiatry; 1977 Dec; 40(12):1136-41. PubMed ID: 591981
    [Abstract] [Full Text] [Related]

  • 20. HVA and 5HIAA CSF measurements and 5HTP trials in some patients with involuntary movements.
    Guilleminault C, Tharp BR, Cousin D.
    J Neurol Sci; 1973 Apr; 18(4):435-41. PubMed ID: 4540626
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.